These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 26271833

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Wen Y, Palladino G, Xie Y, Ferrari A, Settembre EC.
    Vaccine; 2018 May 17; 36(21):3010-3017. PubMed ID: 29680201
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.
    Lorbetskie B, Wang J, Gravel C, Allen C, Walsh M, Rinfret A, Li X, Girard M.
    Vaccine; 2011 Apr 18; 29(18):3377-89. PubMed ID: 21397719
    [Abstract] [Full Text] [Related]

  • 7. A hemagglutinin quantification method for development of an influenza pandemic vaccine using size exclusion high performance liquid chromatography.
    Roh HS, Song HM, Yun BR, Kang HK, Choi KS, Park YJ, Kim DS, Kim SH, Mo IP, An BS, Ahn CY.
    Mol Med Rep; 2015 Apr 18; 11(4):2819-24. PubMed ID: 25482872
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.
    Gravel C, Li C, Wang J, Hashem AM, Jaentschke B, Van Domselaar G, He R, Li X.
    J Vis Exp; 2011 Apr 04; (50):. PubMed ID: 21490585
    [Abstract] [Full Text] [Related]

  • 10. An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
    Bodle J, Vandenberg K, Laurie K, Barr IG, Zhang Y, Rockman S.
    Front Immunol; 2023 Apr 04; 14():1147028. PubMed ID: 37033922
    [Abstract] [Full Text] [Related]

  • 11. Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay.
    Chae W, Kim P, Hwang BJ, Seong BL.
    Vaccine; 2019 Mar 07; 37(11):1457-1466. PubMed ID: 30765169
    [Abstract] [Full Text] [Related]

  • 12. HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines.
    Kapteyn JC, Porre AM, de Rond EJ, Hessels WB, Tijms MA, Kessen H, Slotboom AM, Oerlemans MA, Smit D, van der Linden J, Schoen P, Thus JL.
    Vaccine; 2009 Feb 25; 27(9):1468-77. PubMed ID: 19110022
    [Abstract] [Full Text] [Related]

  • 13. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China.
    Li C, Shao M, Cui X, Song Y, Li J, Yuan L, Fang H, Liang Z, Cyr TD, Li F, Li X, Wang J.
    Biologicals; 2010 Mar 25; 38(2):284-9. PubMed ID: 20074976
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies.
    Chae W, Kim P, Kim H, Cheong YC, Kim YS, Kang SM, Seong BL.
    Sci Rep; 2019 Dec 23; 9(1):19675. PubMed ID: 31873147
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.
    Creskey MC, Li C, Wang J, Girard M, Lorbetskie B, Gravel C, Farnsworth A, Li X, Smith DG, Cyr TD.
    Vaccine; 2012 Jul 06; 30(32):4762-70. PubMed ID: 22643214
    [Abstract] [Full Text] [Related]

  • 17. Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.
    Wheatley AK, Kent SJ.
    Expert Rev Vaccines; 2015 Jul 06; 14(9):1227-39. PubMed ID: 26175180
    [Abstract] [Full Text] [Related]

  • 18. Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method.
    Kapteyn JC, Saidi MD, Dijkstra R, Kars C, Tjon JC, Weverling GJ, de Vocht ML, Kompier R, van Montfort BA, Guichoux JY, Goudsmit J, Lagerwerf FM.
    Vaccine; 2006 Apr 12; 24(16):3137-44. PubMed ID: 16490287
    [Abstract] [Full Text] [Related]

  • 19. Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines.
    Legastelois I, Chevalier M, Bernard MC, de Montfort A, Fouque M, Pilloud A, Serraille C, Devard N, Engel O, Sodoyer R, Moste C.
    J Virol Methods; 2011 Dec 12; 178(1-2):129-36. PubMed ID: 21907241
    [Abstract] [Full Text] [Related]

  • 20. Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine.
    Li C, Xu K, Hashem A, Shao M, Liu S, Zou Y, Gao Q, Zhang Y, Yuan L, Xu M, Li X, Wang J.
    Hum Vaccin Immunother; 2015 Dec 12; 11(6):1351-6. PubMed ID: 25970793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.